Daily Recap: Health — 20 October 2026

Today’s health news centers on strain and uncertainty across care, prevention, and innovation. Public health officials confront outbreaks and vaccination risks, hospitals warn of unsafe capacity pressures, and new tools and pricing debates show how fast medicine is changing even...

The United States records more than 4,400 measles cases in 2026, and the CDC adds a third measles-related death to its national tracker. The update underscores the scale of the outbreak this year and renews attention on containment, vaccination coverage, and the risk of severe outcomes from a highly contagious disease.

Emergency doctors in the UK warn that winter could push accident and emergency services into unsafe conditions as demand rises. They say overcrowding, long waits, and treatment in corridors are likely to worsen, raising the risk that hospitals struggle to deliver timely emergency care during a period of intense pressure on the NHS.

New modeling studies project that moving away from routine hepatitis B vaccination at birth in the United States would lead to more chronic infections in children. The research finds that delaying newborn shots or making them discretionary increases projected harm over time, reinforcing the public health value of immediate universal vaccination.

Anambra State confirms a Lassa fever case in Ayamelum Local Government Area and launches contact tracing and surveillance to prevent further spread. The response focuses on the Omasi community, with health authorities activating emergency measures that include tracing contacts, monitoring possible transmission, and arranging treatment for the confirmed case.

Researchers say a deep-learning system can estimate biological age and help predict cancer survival using a single facial selfie. The tool analyzes facial features in an image to generate health-related risk signals, pointing to a possible new way to assess prognosis, while also raising questions about how such technology might be used in clinical settings.

A new analysis finds that most newly launched drugs still enter the market at prices well above common cost-effectiveness thresholds. Looking at net launch prices from 2022 through 2025, the review shows that even after discounts and inflation adjustments, many medicines remain priced at levels that intensify pressure on patients, insurers, and health systems.

Christina Applegate says she has learned she does not have multiple sclerosis after previously sharing that she was diagnosed with the disease in 2021. Her account points to a major reversal in her medical history and highlights the consequences of misdiagnosis as she reassesses the cause of her symptoms and next steps in treatment.

The National Board of Examinations in Medical Sciences releases city intimation slips for the October 2026 Foreign Medical Graduate Examination. Registered candidates can now check their allotted exam city online ahead of the test, which is scheduled for October 31, an administrative step for doctors seeking licensure pathways in India.